Household costs of illness during different phases of tuberculosis treatment in Central Asia: A patient survey in Tajikistan

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Ayé, Raffael ^a   Wyss, Kaspar ^a   Abdualimova, Hanifa ^b   Saidaliev, Sadullo ^c  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b Project Sino   (Tajikistan)

^c Republican Centre for Tuberculosis Control   (Tajikistan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; COST OF ILLNESS; DIRECTLY OBSERVED THERAPY; ECONOMICS; FAMILY SIZE; FEMALE; HUMAN; MALE; PATIENT CARE; QUESTIONNAIRE; TAJIKISTAN; TUBERCULOSIS;

ADULT; COHORT STUDIES; COST OF ILLNESS; DIRECTLY OBSERVED THERAPY; EPISODE OF CARE; FAMILY CHARACTERISTICS; FEMALE; HUMANS; MALE; QUESTIONNAIRES; TAJIKISTAN; TUBERCULOSIS;

EID: 77149155300     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-18     Document Type: Article

References (41)

1. The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acquired immunodeficiency syndrome. S Russell, Am J Trop Med Hyg 2004 71 Suppl 2 147 155 15331831
2. What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts? D McIntyre M Thiede G Dahlgren M Whitehead, Soc Sci Med 2006 62 858 865 10.1016/j.socscimed. 2005.07.001 16099574
3. Household strategies to cope with the economic costs of illness. R Sauerborn A Adams M Hien, Soc Sci Med 1996 43 291 301 10.1016/0277-9536(95) 00375-4 8844932
4. World Health Organisation, Treatment of tuberculosis-guidelines for national programmes World Health Organisation, Geneva 2003
5. Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. C Murray E DeJonghe H Chum D Nyangulu A Salomao K Styblo, The Lancet 1991 338 8778 1305 1308 10.1016/0140-6736(91)92600-7
6. Review of published cost-effectiveness studies on tuberculosis treatment programmes. R Fryatt, Int J Tuberc Lung Dis 1997 1 101 109 9441072
7. An economic evaluation of alternative programme designs for tuberculosis control in rural Uganda. P Saunderson, Soc Sci Med 1995 40 1203 1212 10.1016/0277-9536(94)00240-T 7610426
8. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi. K Floyd J Skeva T Nyirenda F Gausi F Salaniponi, Int J Tuberc Lung Dis 2003 7 Suppl 29 37
9. A cost-effectiveness analysis of directly observed therapy vs selfadministered therapy for treatment of tuberculosis. W Burman C Dalton D Cohn J Butler R Reves, Chest 1997 112 63 70 10.1378/chest.112.1.63 9228359 (Pubitemid 27343601)
10. The World Bank, World Development Report 1993. Investing in Health Oxford: Oxford University Press 1993
11. Costs and effectiveness - the impact of economic studies on TB control. K Floyd, Tuberculosis 2003 83 187 200 10.1016/S1472-9792(02)00077-X 12758211
12. Economic impact of tuberculosis at the household level. P Kamolratanakul H Sawert S Kongsin S Lertmaharit J Sriwongsa S Na-Songkhla S Wangmanee S Jittimanee V Payanandana, Int J Tuberc Lung Dis 1999 3 596 602 10423222
13. Costs of tuberculosis for households and health care providers in Dar es Salaam, Tanzania. K Wyss P Kilima N Lorenz, Trop Med Int Health 2001 6 60 68 10.1046/j.1365-3156.2001.00677.x 11251897
14. Poverty and the economic effects of TB in rural China. S Jackson A Sleigh G-J Wang X-L Liu, Int J Tuberc Lung Dis 2006 10 1104 1110 17044202
15. Delays to treatment and out-of-pocket medical expenditure for tuberculosis patients, in an urban area of South America. M Lambert R Delgado G Michaux A Volz N Speybroeck P Van Der Stuyft, Ann Trop Med Parasitol 2005 99 781 787 10.1179/136485905X65152 16297291
16. Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis. D Needham P Godfrey-Faussett S Foster, Int J Tuberc Lung Dis 1998 2 811 817 9783528
17. Can Malawi's poor afford free tuberculosis services? Patient and household costs associated with a tuberculosis diagnosis in Lilongwe. J Kemp G Mann B Simwaka F Salaniponi S Squire, Bull World Health Org 2007 85 580 585 10.2471/BLT.06.033167 17768515
18. Central Intelligence Agency, The World Factbook https://www.cia.gov/ library/publications/the-world-factbook/geos/ti.html
19. Republic of Tajikistan Poverty Assessment Update. The World Bank, 2005 Report No: 30853-TJ, Dushanbe
20. Perceived Corruption Index. Transparency International, http://www.transparency.org/policy-research/surveys-indices/cpi/2008
21. Republic of Tajikistan Health Sector Note. The World Bank, 2004 Report, Dushanbe
22. Poverty, out-of-pocket payments and access to health care: evidence from Tajikistan. J Falkingham, Soc Sci Med 2004 58 247 258 10.1016/S0277-9536(03) 00008-X 14604611
23. Access to medicines and out of pocket payments for primary care: evidence from family medicine users in rural Tajikistan. F Tediosi R Ayé Sh Ibodova R Thompson K Wyss, BMC Health Serv Res 2008 18500995
24. Global Tuberculosis Control: Surveillance, Planning, Financing. World Health Organisation, WHO Report 2008
25. Management of pulmonary tuberculosis in Tajikistan: which factors determine hospitalisation? C Thierfelder K Makowiecka T Vinichenko R Ayé P Edwards K Wyss, Trop Med Int Health 2008 13 1364 1371 10.1111/j.1365-3156. 2008.02149.x 19055621
26. Enabling health systems in tuberculosis control: challenges and opportunities for the former Soviet Union countries. A Mosneaga E Yurasova R Zaleskis W Jakubowiak, Health Systems and the Challenge of Communicable Disease Experiences from Europe and Latin America-European Observatory on Health Systems and Policies Series New York: Open University Press, Coker R, Atun R, McKee M, 2008 171 192
27. Reforming tuberculosis control in Ukraine: results of pilot projects and implications for the national scale-up of DOTS. A Vassall Y Chechulin I Raykhert N Osalenko S Svetlichnaya A Kovalyova M van der Werf L Turchenko E Hasker K Miskinis J Veen R Zaleskis, Health Policy Plan 2008 24 55 62 10.1093/heapol/czn045 19056804
28. Costs attributable to AIDS at household level in Chad. K Wyss G Hutton Y N'Diekhor, AIDS Care 2004 16 808 816 10.1080/09540120412331290167 15385235
29. The 2005 International Comparisons Program Report. The World Bank, Washington 2008
30. Handling Missing Data in Patient-Level Cost-Effectiveness Analysis alongside Randomised Clinical Trials. A Manca S Palmer, Appl Health Econ Health Policy 2005 4 65 75 10.2165/00148365-200504020-00001 16162026
31. Analysis of Incomplete Multivariate Data. J Schafer, London: Chapman & Hall 1997
32. Multiple Imputation of Missing Values: update. P Royston, The Stata Journal 2005 5 188 201
33. Estimating wealth effects without expenditure data-or tears: an application to educational enrollments in states of India. D Filmer L Pritchett, Demography 2001 38 115 132 11227840
34. The Use of Discrete Data in PCA: Theory, Simulations and Applications to Socioeconomic Indices. S Kolenikov G Angeles, Technical Report, Carolina Population Center, University of North Carolina, Chapel Hill 2004 59 http://www.cpc.unc.edu/measure/publications/pdf/wp-04-85.pdf
35. Patient's site of first access to health system influences length of delay for tuberculosis treatment in Tajikistan. R Ayé K Wyss H Abdualimova S Saidaliev, BMC Health Serv Res 2010 10 10 10.1186/1472-6963-10-10 20064224
36. An ethnography of nonadherence: culture, poverty, and tuberculosis in urban Bolivia. J Greene, Cult Med Psychiatry 2004 28 401 425 10.1023/B:MEDI.0000046429.55801.c8 15600119
37. Tuberculosis, poverty and "compliance": lessons from rural Haiti. P Farmer S Robin St Luc Ramilus J Kim Yong, Sem Resp Inf 1991 6 254 260
38. Social support and incentives programme for patients with tuberculosis: experience from the Russian Federation. W Jakubowiak E Bogorodskaya S Borisov I Danilova O Lomakina E Kourbatova, Int J Tuberc Lung Dis 2007 11 1210 1215 17958983
39. Tuberculosis control in Samara Oblast, Russia: institutional and regulatory environment. R Coker B Dimitrova F Drobniewski Y Samyshkin Y Balabanova S Kuznetsov I Fedorin A Melentsiev G Marchenko S Zakharova R Atun, Int J Tuberc Lung Dis 2003 7 920 932 14552561
40. Cost-effectiveness analysis of the Russian treatment scheme for tuberculosis versus short-course chemotherapy: results from Tomsk, Siberia. B Jacobs C Clowes F Wares V Polivakho T Lyagoshina G Peremitin N Banatvala, Int J Tuberc Lung Dis 2002 6 396 405 12019915
41. Social factors influencing hospital utilisation by tuberculosis patients in the Russian Federation: analysis of routinely collected data. R Atun Y Samyshkin F Drobniewski S Kuznetsov I Fedorin R Coker, Int J Tuberc Lung Dis 2005 9 1140 1146 16229226